These studies demonstrate that E2 indeed regulates the transcription of HOXA5 in vitro, in ER-positive breast cancer cells (MCF7), and this expression is suppressed upon treatment with an antiestrogen, tamoxifen, suggesting the potential regulation of HOXA5 via E2 and ERs. This evidence concerns the gene HOXA5 and breast carcinoma.